3rd Mastering HR Summit 2012

North West Business Group22 - 23 February 2012, Istanbul, Turkey.
The role of Human Resources is changing as fast as technology and the global marketplace. Historically, the HR department was viewed as administrative overhead.

HR processed payroll, handled benefits administration, kept personnel files and other records, managed the hiring process, and provided other administrative support to the business. Those times have changed. The positive result of these changes is that HR professionals have the opportunity to play a more strategic role in the business. The challenge for HR managers is to keep up to date with the latest HR innovations - technological, legal, and otherwise.

The 3rd Mastering HR Summit 2012 will discuss the best practices in HR management, in other words how HR managers can anticipate and address some of the most challenging HR issues this year.

The event will give you the information you need to know about these current HR challenges and how to most effectively manage them in your workplace. This forum sets a platform for practitioners from around the world to discuss and share strategies for their future success.

The event will focus on the most current topics in the HR industry such as:

  • Inclusive Talent Management as an enabler of business turnaround
  • How Connecting Performance Management & Talent is going to help you?
  • New perspectives for very experienced persons (VEPs)
  • Working with an HR Strategy to ensure employee retention & effective performance
  • Managing Talent from different cultures with a global model
  • How to connect HR investments to the firm's bottom line
  • HR Transformation and engagement - Business case
  • TQM Tools for employee empowerment
  • Motivation and benefit systems and their impact on performance - a critical view
  • How to set the strategic agenda for Human Resources

Joins some of the experts like:

  • President EAPM, Secretary General WFPMA
  • The Hertz Corporation, Vice President - Global Talent Management
  • Tetra Pak, VP Human Resources, Packaging Solutions & Cluster Coordination
  • Medtronic, Vice President Human Resources Europe & Central Asia
  • Ericsson, Vice President Human Resources & Organization
  • Beiersdorf AG, Regional HR Vice President, Asia and Australia
  • Schneider Electric France, HR Vice President Country Partner
  • Papyrus Group, Senior Vice President Human Resources
  • Citi, Senior Vice President Human Resources EMEA Consumer
  • Mercedes-Benz, General Manager – Business Support
  • Swisscom, Head Group Talent Management
  • Vodafone, Human Resources Director
  • BNP Paribas, Head of UK Recruitment & European Campus Recruitment
  • Eczacıbaşı Holding, HR Director, Corporate Human Resources
  • Gulf Bridge International, Director of HR & Corporate Planning
  • Abdiibrahim, HR Manager
  • TÜV SÜD, Former Head of Division Academy
  • And many more...

Hear from experts actively working in the industry for corporates;

  • Employing close to 1 million people.
  • Operating in more than 250 countries.
  • Presented in 6 continents.
  • With 191€ billion in revenue (2010).

This conference is designed to attract key decision makers from the HR industry with key job titles including: Managing Directors, Country Managers, General Managers, Vice Presidents, Regional Directors/ Heads, Directors, Department Heads, Managers.

Benefits of attending include:

  • Hearing from experts actively working in the industry
  • Participating in the panel discussions
  • Quizzing industry experts on the ideas that worked
  • Exchanging ideas with senior professionals across Europe

After this two day conference, you will be empowered to lead your HR team as a true strategic partner that will improve your organization's competitive advantages and sustainability.

For further information and registration, please visit:
http://nwbg.eu/all-events/3rd-master-hr-sumit-2011/

Most Popular Now

BioNTech's statement on patent infringement lawsui…

BioNTech SE (Nasdaq: BNTX, "BioNTech") published an official statment: "BioNTech is aware of reports that Moderna has sued Pfizer and BioNTech, alleging that COMIRNATY® i...

Xenpozyme™ (olipudase alfa-rpcp) approved by FDA a…

The U.S. Food and Drug Administration (FDA) has approved Xenpozyme™ (olipudase alfa-rpcp) for the treatment of non-central nervous system (non-CNS) manifestations of acid...

FDA grants Breakthrough Therapy Designation to Pfi…

Pfizer Inc. (NYSE:PFE) today announced that its investigational Group B Streptococcus (GBS) vaccine candidate, GBS6 or PF-06760805, received Breakthrough Therapy Designat...

Malaria booster vaccine shows durable high efficac…

Researchers from the University of Oxford and their partners have today reported new findings from their Phase 2b trial following the administration of a booster dose of ...

Research reveals widespread use of ineffective COV…

Monoclonal antibodies are laboratory-designed treatments tailor-made to fight specific infections. In early 2021, the U.S. Food & Drug Administration issued emergency use...

Efficacy, cash and more will increase booster shot…

The more effective the COVID-19 booster, the more likely people are to get it, according to new Cornell research. And they are more likely to accept the booster shot with...

Strict COVID lockdowns in France improved cardiova…

A new paper in European Heart Journal - Digital Health, published by Oxford University Press, indicates that social-distancing measures like total lockdown have a measura...

U.S. clinical trial evaluating antiviral for monke…

A Phase 3 clinical trial evaluating the antiviral tecovirimat, also known as TPOXX, is now enrolling adults and children with monkeypox infection in the United States. St...

Stem cell-gene therapy shows promise in ALS safety…

Cedars-Sinai investigators have developed an investigational therapy using support cells and a protective protein that can be delivered past the blood-brain barrier. This...

Novartis invests in early technical development ca…

Novartis today announced it is investing in next-generation biotherapeutics with the creation of a fully integrated, dedicated USD 300m scientific environment that will b...

Drug turns cancer gene into "eat me" fla…

Tumor cells are notoriously good at evading the human immune system; they put up physical walls, wear disguises and handcuff the immune system with molecular tricks. Now...

Mucosal antibodies in the airways protect against …

High levels of mucosal antibodies in the airways reduce the risk of being infected by omicron, but many do not receive detectable antibodies in the airways despite three ...